Clinical evaluation of jalauka avacharana in the management of dushta vrana with special reference to madhumehaj vrana

VYDS AYURVEDA MAHAVIDHLAYA0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年5月29日

研究概览

暂无简介。

•1.Patients with clinical features of Dustha Vrana w.s.r. Madhumehaja Vrana (diabetic ulcer)
•will be included.
•2. Patients of both sexes between 25 to 60 years of age will be included in the study.
•3. Patients with Fasting blood sugar level ranging between 70-130mg/dl and random blood
•sugar level ranging between 70-150 mg/dl will be included.
•4.Patients with Hb level ranging between 10-16g/dl will be included.
•5. Patients willing to give a consent to perform the therapy will be included.
•6.Patients with bleeding time ranging between 2-9 min and clotting time between 10-13 sec
•will be included.
•7.Patients with ulcer size less than or equal to 6cm from the widest dimension of the ulcer
•will be included.

•1.Patients with Hb level below 10g/dl will be excluded.
•2. Patients with acute features and with complications like gangrene will be excluded.
•3. Patients with peripheral vascular diseases like Raynaudâ??s disease, Buergerâ??s disease, DVT
•and Arterial and Venous ulcers will be excluded.
•4. Patients associated with any other systemic diseases and HIV, HBsAg, HCV, VDRL will
•be excluded.
•5. Patients with ulcer size more than 6cm will be excluded.

发起方

VYDS AYURVEDA MAHAVIDHLAYA